Modafinil and blood alkaline phosphatase increased Patient Reports February 11, 2012

Modafinil Side Effects Report #5762019-8
Modafinil side effect was reported by a Health Professional from JAPAN on May 21, 2008. Male patient, 63 years of age, was diagnosed with sleep apnoea syndrome and was treated with Modafinil. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase decreased, pancreatic neoplasm. Modafinil dosage: 200 MG QD ORAL. During the same period patient was treated with DEXART, LIDOCAINE. Patient was hospitalized. Patient recovered.

Modafinil Side Effects Report #5776633-7
Modafinil side effect was reported by a Health Professional from JAPAN on June 03, 2008. Male patient, 63 years of age, was diagnosed with sleep apnoea syndrome and was treated with Modafinil. After drug was administered, patient experienced the following side effects: adenoma benign, atrophy, biliary dilatation, blood alkaline phosphatase increased, dilatation intrahepatic duct acquired, gamma-glutamyltransferase increased, gastric disorder, pancreatic carcinoma, pancreatic duct dilatation. Modafinil dosage: 200 MG QD ORAL. During the same period patient was treated with DEXART, LIDOCAINE. Patient was hospitalized. Patient recovered.

Modafinil Side Effects Report #5817462-5
Modafinil side effect was reported by a Physician from JAPAN on June 30, 2008. Male patient, 63 years of age, was diagnosed with sleep apnoea syndrome and was treated with Modafinil. After drug was administered, patient experienced the following side effects: adenoma benign, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, pancreatic neoplasm. Modafinil dosage: 200 MG QD ORAL. During the same period patient was treated with DEXART, LIDOCAINE. Patient was hospitalized. Patient recovered.

Modafinil Side Effects Report #5832479-2
Modafinil side effect was reported by a Consumer or non-health professional from JAPAN on July 18, 2008. Male patient, 63 years of age, was diagnosed with sleep apnoea syndrome and was treated with Modafinil. After drug was administered, patient experienced the following side effects: adenoma benign, atrophy, benign duodenal neoplasm, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, gastric disorder, pancreatic carcinoma, pancreatic neoplasm, reflux oesophagitis. Modafinil dosage: 200 MG QD ORAL. During the same period patient was treated with DEXART, LIDOCAINE. Patient was hospitalized. Patient recovered.